Budillon A - Search Results

1

Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma.

Fattore L, Ruggiero CF, Pisanu ME, Liguoro D, Cerri A, Costantini S, Capone F, Acunzo M, Romano G, Nigita G, Mallardo D, Ragone C, Carriero MV, Budillon A, Botti G, Ascierto PA, Mancini R, Ciliberto G. Fattore L, et al. Among authors: budillon a. Cell Death Differ. 2019 Jul;26(7):1267-1282. doi: 10.1038/s41418-018-0205-5. Epub 2018 Sep 25. Cell Death Differ. 2019. PMID: 30254376 Free PMC article.

2

EGF activates an inducible survival response via the RAS-> Erk-1/2 pathway to counteract interferon-alpha-mediated apoptosis in epidermoid cancer cells.

Caraglia M, Tagliaferri P, Marra M, Giuberti G, Budillon A, Gennaro ED, Pepe S, Vitale G, Improta S, Tassone P, Venuta S, Bianco AR, Abbruzzese A. Caraglia M, et al. Among authors: budillon a. Cell Death Differ. 2003 Feb;10(2):218-29. doi: 10.1038/sj.cdd.4401131. Cell Death Differ. 2003. PMID: 12700650

3

C-Raf antagonizes apoptosis induced by IFN-alpha in human lung cancer cells by phosphorylation and increase of the intracellular content of elongation factor 1A.

Lamberti A, Longo O, Marra M, Tagliaferri P, Bismuto E, Fiengo A, Viscomi C, Budillon A, Rapp UR, Wang E, Venuta S, Abbruzzese A, Arcari P, Caraglia M. Lamberti A, et al. Among authors: budillon a. Cell Death Differ. 2007 May;14(5):952-62. doi: 10.1038/sj.cdd.4402102. Epub 2007 Mar 2. Cell Death Differ. 2007. PMID: 17332776

4

Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells.

Milone MR, Pucci B, Bruzzese F, Carbone C, Piro G, Costantini S, Capone F, Leone A, Di Gennaro E, Caraglia M, Budillon A. Milone MR, et al. Among authors: budillon a. Cell Death Dis. 2013 May 23;4(5):e641. doi: 10.1038/cddis.2013.165. Cell Death Dis. 2013. PMID: 23703386 Free PMC article.

5

Proteomic analysis of zoledronic-acid resistant prostate cancer cells unveils novel pathways characterizing an invasive phenotype.

Milone MR, Pucci B, Bifulco K, Iannelli F, Lombardi R, Ciardiello C, Bruzzese F, Carriero MV, Budillon A. Milone MR, et al. Among authors: budillon a. Oncotarget. 2015 Mar 10;6(7):5324-41. doi: 10.18632/oncotarget.2694. Oncotarget. 2015. PMID: 25481874 Free PMC article.

6

Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway.

Leone A, Roca MS, Ciardiello C, Terranova-Barberio M, Vitagliano C, Ciliberto G, Mancini R, Di Gennaro E, Bruzzese F, Budillon A. Leone A, et al. Among authors: budillon a. Free Radic Biol Med. 2015 Dec;89:287-99. doi: 10.1016/j.freeradbiomed.2015.07.155. Epub 2015 Sep 26. Free Radic Biol Med. 2015. PMID: 26409771

7

Synergistic antitumor activity of histone deacetylase inhibitors and anti-ErbB3 antibody in NSCLC primary cultures via modulation of ErbB receptors expression.

Ciardiello C, Roca MS, Noto A, Bruzzese F, Moccia T, Vitagliano C, Di Gennaro E, Ciliberto G, Roscilli G, Aurisicchio L, Marra E, Mancini R, Budillon A, Leone A. Ciardiello C, et al. Among authors: budillon a. Oncotarget. 2016 Apr 12;7(15):19559-74. doi: 10.18632/oncotarget.7195. Oncotarget. 2016. PMID: 26862736 Free PMC article.

8

Potential Anticancer Effects of Polyphenols from Chestnut Shell Extracts: Modulation of Cell Growth, and Cytokinomic and Metabolomic Profiles.

Sorice A, Siano F, Capone F, Guerriero E, Picariello G, Budillon A, Ciliberto G, Paolucci M, Costantini S, Volpe MG. Sorice A, et al. Among authors: budillon a. Molecules. 2016 Oct 21;21(10):1411. doi: 10.3390/molecules21101411. Molecules. 2016. PMID: 27775667 Free PMC article.

9

Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.

Noto A, De Vitis C, Pisanu ME, Roscilli G, Ricci G, Catizone A, Sorrentino G, Chianese G, Taglialatela-Scafati O, Trisciuoglio D, Del Bufalo D, Di Martile M, Di Napoli A, Ruco L, Costantini S, Jakopin Z, Budillon A, Melino G, Del Sal G, Ciliberto G, Mancini R. Noto A, et al. Among authors: budillon a. Oncogene. 2017 Aug 10;36(32):4573-4584. doi: 10.1038/onc.2017.75. Epub 2017 Apr 3. Oncogene. 2017. PMID: 28368399

10

Oxidative Stress Gene Expression Profile Correlates with Cancer Patient Poor Prognosis: Identification of Crucial Pathways Might Select Novel Therapeutic Approaches.

Leone A, Roca MS, Ciardiello C, Costantini S, Budillon A. Leone A, et al. Among authors: budillon a. Oxid Med Cell Longev. 2017;2017:2597581. doi: 10.1155/2017/2597581. Epub 2017 Jul 9. Oxid Med Cell Longev. 2017. PMID: 28770020 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

224 results

Search Page